Nurofen

Nurofen is one of the world's most recognized brands for pain management, utilizing Ibuprofen as its active ingredient. It was first introduced to the consumer market in the United Kingdom following the discovery of ibuprofen's analgesic properties by researchers at the Boots Company in the 1960s. Since its commercial launch in 1983, it has grown into a global household name for addressing headaches, fever, and inflammatory pain.

Manufacturing of Nurofen products takes place in various global locations to satisfy regional demand, including significant facilities in the United Kingdom, Thailand, and Australia. The brand underwent a major shift in ownership when Boots Healthcare International was acquired by Reckitt Benckiser in 2006.

Today, Nurofen is a flagship brand within the portfolio of Reckitt (formerly Reckitt Benckiser), a British multinational consumer goods giant. Reckitt manages the brand's global distribution and ongoing product innovation from its headquarters in Slough, England. Depending on the specific market, the product may be distributed by local Reckitt subsidiaries, ensuring compliance with diverse national pharmaceutical regulations.